相似文献
1
Antibody avidity maturation during severe acute respiratory syndrome-associated coronavirus infection.
J Infect Dis. 2005 Jul 1;192(1):166-9. doi: 10.1086/430615. Epub 2005 May 25.
2
Use of antibody avidity assays for diagnosis of severe acute respiratory syndrome coronavirus infection.
Clin Vaccine Immunol. 2007 Nov;14(11):1433-6. doi: 10.1128/CVI.00056-07. Epub 2007 Sep 19.
3
Longitudinal profiles of immunoglobulin G antibodies against severe acute respiratory syndrome coronavirus components and neutralizing activities in recovered patients.
Scand J Infect Dis. 2011 Jul;43(6-7):515-21. doi: 10.3109/00365548.2011.560184. Epub 2011 Mar 2.
4
Natural course of severe acute respiratory syndrome-associated coronavirus immunoglobulin after infection.
J Infect Dis. 2004 Nov 1;190(9):1706-7; author reply 1707. doi: 10.1086/424573.
5
Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus.
Clin Microbiol Infect. 2004 Dec;10(12):1062-6. doi: 10.1111/j.1469-0691.2004.01009.x.
6
Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus.
Clin Diagn Lab Immunol. 2004 Jul;11(4):665-8. doi: 10.1128/CDLI.11.4.665-668.2004.
7
Kinetics of severe acute respiratory syndrome (SARS) coronavirus-specific antibodies in 271 laboratory-confirmed cases of SARS.
Clin Diagn Lab Immunol. 2004 Jul;11(4):792-4. doi: 10.1128/CDLI.11.4.792-794.2004.
8
[A follow up study of total IgM, IgG, nucleoprotein and spike protein antibodies against severe acute respiratory syndrome (SARS) coronavirus in patients with SARS].
Zhonghua Nei Ke Za Zhi. 2006 Nov;45(11):896-9.
9
Duration of antibody responses after severe acute respiratory syndrome.
Emerg Infect Dis. 2007 Oct;13(10):1562-4. doi: 10.3201/eid1310.070576.
引用本文的文献
1
Rapid, sensitive, and species-independent detection of Crimean Congo hemorrhagic fever virus nucleoprotein and GP38 antibodies.
EBioMedicine. 2025 Jul 23;118:105857. doi: 10.1016/j.ebiom.2025.105857.
2
Moloney Murine Leukemia Virus-like Nanoparticles Pseudo-Typed with SARS-CoV-2 RBD for Vaccination Against COVID-19.
Int J Mol Sci. 2025 Jul 4;26(13):6462. doi: 10.3390/ijms26136462.
3
Primary SARS-CoV-2 infection in children and adults results in similar Fc-mediated antibody effector function patterns.
Clin Transl Immunology. 2024 Jul 26;13(8):e1521. doi: 10.1002/cti2.1521. eCollection 2024.
4
SARS-CoV-2 spike-specific T cells exhibit unique responses in infected and vaccinated individuals.
Signal Transduct Target Ther. 2023 Oct 6;8(1):393. doi: 10.1038/s41392-023-01650-x.
5
Production of Recombinant Zika Virus Envelope Protein by Airlift Bioreactor as a New Subunit Vaccine Platform.
Int J Mol Sci. 2023 Sep 11;24(18):13955. doi: 10.3390/ijms241813955.
6
Assessment of antibody dynamics and neutralizing activity using serological assay after SARS-CoV-2 infection and vaccination.
PLoS One. 2023 Sep 19;18(9):e0291670. doi: 10.1371/journal.pone.0291670. eCollection 2023.
7
Oral Immunization with Expressing SARS-CoV-2 Spike Protein Induces Mucosal and Systemic Antibody Responses in Mice.
Biomolecules. 2023 Mar 21;13(3):569. doi: 10.3390/biom13030569.
8
RBD and Spike DNA-Based Immunization in Rabbits Elicited IgG Avidity Maturation and High Neutralizing Antibody Responses against SARS-CoV-2.
Viruses. 2023 Feb 17;15(2):555. doi: 10.3390/v15020555.
9
Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies.
Sci Rep. 2022 Sep 1;12(1):14909. doi: 10.1038/s41598-022-19073-z.
10
Avidity of IgG to SARS-CoV-2 RBD as a Prognostic Factor for the Severity of COVID-19 Reinfection.
Viruses. 2022 Mar 16;14(3):617. doi: 10.3390/v14030617.
本文引用的文献
1
Immunofluorescence assay for serologic diagnosis of SARS.
Emerg Infect Dis. 2004 Mar;10(3):530-2. doi: 10.3201/eid1003.030493.
2
Laboratory-acquired severe acute respiratory syndrome.
N Engl J Med. 2004 Apr 22;350(17):1740-5. doi: 10.1056/NEJMoa032565.
3
Comparative evaluation of the use of immunoblots and of IgG avidity assays as confirmatory tests for the diagnosis of acute EBV infections.
J Clin Virol. 1998 Dec;11(3):161-72. doi: 10.1016/s0928-0197(98)00061-0.
4
Differentiation of primary from nonprimary genital herpes infections by a herpes simplex virus-specific immunoglobulin G avidity assay.
J Clin Microbiol. 1997 Jul;35(7):1766-8. doi: 10.1128/jcm.35.7.1766-1768.1997.
5
Relative functional affinity of specific anti-core IgG in different categories of hepatitis B virus infection.
J Med Virol. 1997 Mar;51(3):189-97. doi: 10.1002/(sici)1096-9071(199703)51:3<189::aid-jmv8>3.0.co;2-2.
6
Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1.
Clin Exp Immunol. 1996 Feb;103(2):185-91. doi: 10.1046/j.1365-2249.1996.951642.x.
7
Hepatitis A virus infection among the hemophilia population at the Bonn Hemophilia Center.
Vox Sang. 1994;67 Suppl 1:3-7; discussion 8.
8
Serological diagnosis of acute tick-borne encephalitis by demonstration of antibodies of the IgM class.
J Med Virol. 1981;7(1):41-50. doi: 10.1002/jmv.1890070105.
9
Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed.
J Clin Microbiol. 1984 Sep;20(3):525-9. doi: 10.1128/jcm.20.3.525-529.1984.
Zotero 插件